![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Bentham Science Publishers
E-ISSN: 1873-5592|16|3|189-193
ISSN: 1389-4501
Source: Current Drug Targets, Vol.16, Iss.3, 2015-03, pp. : 189-193
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Pharmacogenomics and functional gastrointestinal disorders
Pharmacogenomics, Vol. 6, Iss. 5, 2005-07 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Excess primary intestinal lymphoproliferative disorders in patients with inflammatory bowel disease
By Sokol Harry Beaugerie Laurent Maynadié Marc Laharie David Dupas Jean-Louis Flourié Bernard Lerebours Eric Peyrin-Biroulet Laurent Allez Matthieu Simon Tabassome Carrat Fabrice Brousse Nicole
Inflammatory Bowel Diseases, Vol. 18, Iss. 11, 2012-11 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)